Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis

Clinical trial NCT00244543 · COMPLETED

Trial details

NCT number: NCT00244543
Sponsor: Vistakon Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Allergic Conjunctivitis

Start date: 2005-10-01
Primary completion: 2005-11-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.